Cervical Cancer Survival Rate - Dare You Know Your Chances

Previously, cervical cancer survival rates were so poor amongst women. In fact, a long time ago, this type of cancer was the most common cause of cancer death in women. However, in the last 30 years, the mortality rate has decreased by 50% because of the widespread utilization of Pap smear.

In 2004, there were approximately 10,500 new cases of invasive cervical cancer and more than 50,000 cases of carcinoma in situ. There were 3,900 cases of reported death from this disease, but about 85% of them were due to the lack of preventative and detective methods like Pap smear.

Pap smear has an accuracy of almost 90 to 95% in diagnosing early lesions such as CIN. The only disadvantage is that it lacks the diagnostic sensitivity to detect cancer when the tumor or mass is thoroughly invaded with fungus. Inflammation, necrosis and hemorrhage can give false positive smears, and a proper biopsy may have to be used to confirm the existence of cancer. The American Cancer Society recommends that women who live an active sex life or those who are already at the age of 20 undergo annual smears for two consecutive years. If they are negative, the smear should be repeated every three years. This is seconded by American College of Obstetrics and Gynecology as well.

Cervical Cancer Survival Rates by Stage
Stage 0 is also what they call carcinoma in situ while stage I has a tumor that is confined to the cervix. Stage II indicates that the invasion has gone beyond the cervix but does not reach the wall of the pelvis and the lower third of the vagina. Stage III has a tumor that invades the wall of the pelvis or lower third of the vagina or causes hydronephrosis while lastly, stage IV is manifested by invasion of the mucosa of the bladder or rectum or an extension beyond the true pelvis.

Cervical Cancer Survival Rates at five years are reported as follows: stage I: 85%; stage II: 60%; stage III: 33%; and stage IV: 7%.

Carcinoma in situ (stage 0) can be treated successfully by excision of a cone of tissue or abdominal hysterectomy. In stage I the results are apparently comparable with radical hysterectomy and radiotherapy. Patients in stages II to IV are treated primarily with radical radiotherapy or combined modality treatment. Retroperitoneal lymphadenectomy has no proven therapeutic value. Pelvic evisceration, although rare, is performed to treat cancers that cause persistent or recurrent central. After this, intervention is often possible to reconstruct the vagina, bladder and rectum.

In women with locally advanced stages (stages IIB to IVA), cervical cancer survival rates are improved by administering platinum-based chemotherapy along with radiation therapy compared to treatment with radiation alone.

Uterine Cancer Survival Rate - Dare To Know Your Chances

A Uterine cancer survival rate refers to the percentage of people who were reported still living after being diagnosed with the cancer about 5 yrs ago.

Endometrial carcinoma or Uterine Cancer is the most common malignancy of the female population. Each year, there are about 40,300 new cases diagnosed with this type of cancer, although in many occasions (around 75%), the diagnosis is established when the tumor is confined to the body of the uterus, therefore, many tumors can be cured. The 7,000 annual deaths caused by the cancer mean that this tumor ranks as the seventh leading cause of cancer death in women. It is primarily a neoplasm of postmenopausal women, although there are 25% of cases occurring in women under 50 years and 5% in women under 40 years. It is a predominantly common in Eastern Europe and the U.S. but quite rare in Asia.

Phenotypic traits and risk factors common in patients with endometrial cancer are obesity, menstrual disorders, a low fertility rate, late menopause, lack of ovulation and bleeding after menopausal. The risk is doubled in women taking tamoxifen to treat or prevent breast cancer. The maximum age of onset of endometrial carcinoma is the sixth and seventh decades of life. The symptoms are: abnormal vaginal discharge (90%), abnormal bleeding (80%), usually postmenopausal and vaginal discharge (10%). The study of patients with endometrial cancer may require a history and physical and gynecological examination, followed by endometrial biopsy or dilation of the cervix with fractional curettage. It may require an invasive procedure or minor surgery to establish the extent and degree of myometrial invasion or determine the staging. You have to take samples of peritoneal fluid, to explore the abdomen and pelvis, and perform a pelvic lymphadenectomy. As of today, around 74% of the patients are in stage I, 13% in stage II, 9% stage III, and 3% stage IV.

Uterine Cancer Survival rates at five years are as follows: Stage I: 89%, stage II: 80%, stage III: 30%, and stage IV: 9%.

A superficial invasion of the uterus (Stage I) can be treated with chemotherapy, but if the invasion is a bit larger, your doctor may suggest a radical hysterectomy or preoperative radiotherapy followed by extrafascial hysterectomy. About 15% of women with endometrial cancer are in stage II and the treatment depends on the intensity of this invasion. When the process has spread outside the uterus, but remains within the pelvis (stage III), treatment usually consists of surgery plus radiation. Patients whose cancer is only confined in the ovary and fallopian tubes, outcome with this treatment is quite high (80% uterine cancer survival rate at five years). Other stage III patients with a tumor spread beyond the Annexes and those with serous endometrial carcinoma have a significantly worse prognosis (uterine cancer survival rate of 15% at five years).

One Less HPV Vaccine Could Up Your Chances of Cervical Cancer by 44 Percent

In case you didn't know, HPV (Human Papillomavirus) is usually found among sexually active females. It has also been found that most healthy female bodies will fight against this virus on it's own and will successfully rid itself of the virus without any medical intervention. The only danger of cervical cancer developing would be in the instance of persistent re-infection.

So why are we blasting ads on TV and in the news media, along with government mandates for young school aged children? The Journal of the American Medical Association stated in their August 2007 issue that they found no reason to implement this vaccine and that there was no reliable proof that it did what it purported to do which was prevent cervical cancer.

How many physicians actually read their medical journals on a regular basis to get this information? If your's does not---perhaps you should question him on his own information as to the efficacy of this treatment.

Now add, that in the group of women who have persistent re-infection when given the vaccine, there is a 44% increased risk of precancerous cervical lesions and there can be no clear reason why any woman or child should be given this vaccine. The FDA report supporting this information was given by the very manufacturers of the HPV vaccine - Merck.

What about the adverse affects from the vaccine? Have you read any of the statistics? Probably not as these (as far as I know) have not been all over the newspapers and in TV ads. The public interest group, Judicial Watch, released documents obtained from the FDA that reported 1,637 adverse reactions prior to May 2007. There have been numerous reports of fainting, seizures, nausea, swelling of the injection sight, etc. There is also a report related to the number of deaths. Both reports can be downloaded from links on their web site.

The FDA report from Merck page 13, shows the statistics for those who have persistent re-infection. It should be very interesting to all those considering this vaccine that none of this information has been given the coverage that the actual vaccine promotion has been given. You can read the entire article by clicking on the first link on this page at the Natural News site.

Do your own research before having this vaccine given to your young daughters. What is the justification of mandating a vaccine for someone who might not ever become "sexually active"? Or someone who was sexually active but has now become celibate and her own body will take care of the problem, given the time it needs to heal itself?

Don't fall for the hype from the TV ads. They intentionally pull on your heartstrings to make you feel like you are doing the right thing. Their motives are entirely financial. A series of these vaccines (three are recommended), has a cost of $360. If they can get every young woman and female child vaccinated, what are the profits they are pulling in for the pharmaceutical that produces it? You or your daughter's ultimate health is not what they have in mind.

The survival rate of cervical cancer - Dare to know your chances

Long ago, the survival rate of cervical cancer is very low. In fact, it is too low, which is a large number of deaths of women in the United States. With the death rate increasing those under the disease, more women have begun to seek this type of cancer education, "if the consciousness of protecting the lives of women affected and shocked the nation.

To date, the number of lives taken by cancer of the cervix isdecreased with more women appreciate the benefits of early detection through regular Pap tests annually. Why more women are now more aware of their bodies and their health, cervical cancer is now seen from a deadly disease is a disease that can be easily prevented and detected.

Cervical cancer has 4 stages - Stages 1 to 4. In this case, Phase 1 is the first (and least dangerous) and Phase 4 is the most dangerous.

Phase 1 has two phases:Phase 1A and 1B of practice. In phase 1, the survival rate of cervical cancer is very nice from 96 to 99%. Since this is the first stage of their experience with cancer, the tumor is still localized and can be easily taken to surgery. Stage 1B is about 80-90% and the survival rate can be treated with a combination of surgery, chemotherapy and radiotherapy.

In Phase 2, the cancer has proliferated in the surrounding tissue outside the uterus. During afive-year period of time, the survival rate of cervical cancer patients diagnosed at this stage is significantly less than 65-69%. The treatment is the same as in the previous phase, but the dose and frequency of medications and therapy sessions may be longer.

In most cancer cases, cancer is dangerous to stop without treatment up to stage 3. It is at this stage because the prognosis is very poor and the survival rate for cervical cancer is rather low at 40-43%, even with adequate chemotherapy and radiotherapy.

In the fourth stage of the disease, the cancer may have already affected distant organs such as the pelvis and bowel. Even with treatment, the survival rate is still 15-20%.

Cervical cancer is equally common among women with and without children and for women sexually active or not. Like most cancers, direct and preciseCancer> cervix is ​​unknown, but it is vaguely related to the lifestyle of a woman, race and socioeconomic status.

Preventive measures and research mainly suggested by most medical tests are annual or biennial Pap, as soon as a woman begins having sex or eighteen years of age.